March 18th (Thu) Graduate Seminar / Professor Namjoong Kim

by webmaster2 posted May 01, 2023
?

Shortcut

PrevPrev Article

NextNext Article

ESCClose

+ - Up Down Comment Print
Extra Form
Speaker Professor Namjoong Kim (Kyung Hee University Department of Pharmacy)
Date Thursday, March 18, 2021
Time 05:00 PM
Venue ZOOM

A Chemical Knock Down of p38 MAPK as a Novel Therapeutic Approach to Alzheimer’s Disease

 

  P38 MAPK (Mitogen-Activated Protein Kinase) has been considered as a crucial target for chronic inflammatory diseases such as rheumatoid arthritis for past decades. However, targeting the kinase has not been relevant with its clinical utility for the diseases. Alzheimer's disease (AD) is characterized by the presence of amyloid-beta plaques and tau-aggregated neurofibrillary tangles in the brain, as well as neurodegeneration, and there is no known cure. Recent studies on the underlying biology of AD in cellular and animal models have indicated that p38 MAPK is capable of orchestrating diverse events related to AD, such as tau phosphorylation, neurotoxicity, neuroinflammation and synaptic dysfunction. Thus, the modulation of p38 MAPK is a promising strategy for the treatment of AD. Recently, we developed a novel approach to AD by degrading p38 MAPK. In particular, p-p38 MAPK, p38 MAPK active form causing downstream activation as well as aggravating its pathology in the chronic inflammation, is selectively degraded by our approach. In addition, we confirmed that this novel approach is effective for the treatment of AD in the 5X-FAD mouse model. In this seminar, overall strategy towards AD using the selective chemical degradation of p-p38 MAPK will be presented.


Articles

1 2 3 4 5 6 7 8

Designed by sketchbooks.co.kr / sketchbook5 board skin

나눔글꼴 설치 안내


이 PC에는 나눔글꼴이 설치되어 있지 않습니다.

이 사이트를 나눔글꼴로 보기 위해서는
나눔글꼴을 설치해야 합니다.

설치 Cancel

Sketchbook5, 스케치북5

Sketchbook5, 스케치북5

Sketchbook5, 스케치북5

Sketchbook5, 스케치북5